Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy [7]

Yu Hui Hu; Chun Yu Liu; Chao Hua Chiu; Liang Tsai Hsiao

doi:10.1111/j.1600-0609.2006.00801.x

Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy [7]

Yu Hui Hu, Chun Yu Liu, Chao Hua Chiu, Liang Tsai Hsiao

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	176-177
Number of pages	2
Journal	European Journal of Haematology
Volume	78
Issue number	2
DOIs	https://doi.org/10.1111/j.1600-0609.2006.00801.x
Publication status	Published - Feb 2007
Externally published	Yes

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/j.1600-0609.2006.00801.x

Cite this

@article{7ac43820d65f4a09a81262841d60ccc5,

title = "Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy [7]",

author = "Hu, {Yu Hui} and Liu, {Chun Yu} and Chiu, {Chao Hua} and Hsiao, {Liang Tsai}",

year = "2007",

month = feb,

doi = "10.1111/j.1600-0609.2006.00801.x",

language = "English",

volume = "78",

pages = "176--177",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy [7]

AU - Hu, Yu Hui

AU - Liu, Chun Yu

AU - Chiu, Chao Hua

AU - Hsiao, Liang Tsai

PY - 2007/2

Y1 - 2007/2

UR - http://www.scopus.com/inward/record.url?scp=33846117633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846117633&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2006.00801.x

DO - 10.1111/j.1600-0609.2006.00801.x

M3 - Letter

C2 - 17313566

AN - SCOPUS:33846117633

SN - 0902-4441

VL - 78

SP - 176

EP - 177

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 2

ER -

Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy [7]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this